BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20260515T010352
CREATED:20190409T072829Z
LAST-MODIFIED:20190409T072829Z
UID:20257-1561507200-1561593599@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27\, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.  \n\nThe Pharma Gorilla | June 26\, 2019 | Le Meridien Singapore\, Sentosa\nThe Pharma Gorilla | Nov 07\, 2019 | New Delhi\, India\n\n The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe conference program have been designed in such way which can cover the trending topics under Keynote session\, exclusive presentation\, product lunch\, panel and round table discussion and it also provides a meaningful information. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition. \nTarget Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies\, software development companies\, CRO\, manufacturing\, formulation\, digital marketing and data management companies. \nGlimpse of Conference Agenda! \n Conference Panels \n\nArtificial Intelligence in Pharma and Healthcare\nA disruptive take on marketing: Digital Marketing comes to Pharma\nScope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry\nLatest Trends in Formulation Development: A Global Perspective\nThe Impact of Regulatory Reform on Innovation in Drug Delivery Systems\n\nRoundtable Discussion \n\nImproving patient engagement and experience to improve clinical trials\n\n Keynote Session \n\nInnovation-driven and emerging technologies of Pharma Industry in Asia\nThe Global Pharma Industry: Policies\, Regulations and Key Trends 2019-2020\n\nExclusive Presentation \n\nRole of IPR in pharmaceutical industry\nCareer Growth Opportunities in the pharmaceutical industry\nImproving Biosimilars in manufacturing data\n\nFor any query\, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla-2/
LOCATION:Le Meridien Singapore\, Sentosa
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190624
DTEND;VALUE=DATE:20190627
DTSTAMP:20260515T010352
CREATED:20190326T120821Z
LAST-MODIFIED:20190326T121125Z
UID:20086-1561334400-1561593599@www.pharmajournalist.com
SUMMARY:GI Inflammatory Diseases Summit (GIIDS)
DESCRIPTION:Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases \nThe GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease. \nIncorporating insights from leading pharma and pioneering biotech\, this discussion and networking forum will curate the cutting edge insights on: \n\nImproving drug safety profiles of more gut-selective compounds\nOptimizing trial design in a hypercompetitive market\nThe promise of microbiome based biotherapeutics\n\nJoin gastroenterology\, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.
URL:https://www.pharmajournalist.com/event/gi-inflammatory-diseases-summit-giids/
LOCATION:Revere Hotel Boston Common  200 Stuart Street  Boston\, MA\, 02116  USA\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190619
DTEND;VALUE=DATE:20190622
DTSTAMP:20260515T010352
CREATED:20190220T075016Z
LAST-MODIFIED:20190220T075016Z
UID:19657-1560902400-1561161599@www.pharmajournalist.com
SUMMARY:8th Annual HPAPI Summit
DESCRIPTION:Enabling Robust\, Safe and Cost-Effective Productionof Highly Potent APIs \nIn the context of ever-increasing drug potency\, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds\, enabling you to implement safe and robust practices in your own organization. \nIncorporating insights from Genentech\, Pfizer\, Boehringer Ingelheim\, SafeBridge and AbbVie\, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly\, safely and cost-effectively.
URL:https://www.pharmajournalist.com/event/8th-annual-hpapi-summit/
LOCATION:The Westin Waltham Boston  70\, Third Avenue  Waltham\,Boston  Massachusetts 02451
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190618
DTEND;VALUE=DATE:20190621
DTSTAMP:20260515T010352
CREATED:20181113T085750Z
LAST-MODIFIED:20181128T092809Z
UID:18371-1560816000-1561075199@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China 2019
DESCRIPTION:As the most comprehensive pharmaceutical exhibition in Asia\, CPhI & P-MEC China has\, since its launch in 2001\, been fostering international pharmaceutical business exchanges and leading market trends and technical innovations in the entire industry. Based in Shanghai and with a global vision\, CPhI & P-MEC China is emanating its influences by creating a trading & sourcing platform\, gathering quality suppliers\, sharing cutting-edge knowledge\, and building up an elite pharma professional network. \n \nCPhI & P-MEC China 2019 will be held in Shanghai on June 18-20\, 2019. The annual pharma gala are expected to gather 70\,000+ visits and showcase 3\,200+ exhibitors in a 200\,000+ square metre space. Welcome to join us in CPhI & P-MEC China 2019! \n  \nTo learn more and to register online\, visit: http://bit.ly/2r8jnuD
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-2019/
LOCATION:SNIEC\, Shanghai\, China
ORGANIZER;CN="UBM":MAILTO:Yingqi.shi@ubmsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260515T010352
CREATED:20190522T081845Z
LAST-MODIFIED:20190522T081845Z
UID:20818-1559692800-1559865599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2019
DESCRIPTION:Facilitating a platform for the San Diego biotech hub to refine their clinical trial supply strategy to remain patient focused whilst staying at the forefront of an ever-changing landscape. \n2019 will celebrate the 9th year Arena International brings the global Clinical Trial Supply series to San Diego\, giving decision makers from small\, medium and large pharmaceutical companies the opportunity to as inject agility\, transparency and speed into your clinical trial supply. \nThis event brings the unique San Diego biotech hub together to discuss the best methodologies for ensuring successful clinical trial supply. We will focus on the full supply chain\, starting with the front end all the way to site and direct to patient delivery. Delving into the finer details we will ensure the smooth running of trial supplies\, to not only start and finish on time\, but also to meet budgetary constraints. \nAvoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions\, roundtables\, fireside chats and case studies to give rise to innovation solutions to existing challenges. \nThe key topics to be addressed will be: \n\nForecasting and Planning\nPackaging and Labelling\nUnique trial design e.g. adaptive\, compassionate use and at home delivery\nBrexit\nNew technologies\n\nJoin us in June in San Diego to be a part of the discussions and develop unique insight for clinical trial supply.
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2019/
LOCATION:Marriot Del Mar\, San Diego\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190604
DTEND;VALUE=DATE:20190607
DTSTAMP:20260515T010352
CREATED:20171216T022447Z
LAST-MODIFIED:20190404T074100Z
UID:5446-1559606400-1559865599@www.pharmajournalist.com
SUMMARY:Digital Pharma Europe
DESCRIPTION:The 11th Digital Pharma Europe\, hosted by Meck Serono in Rome\, will focus on helping pharma understand how to evolve and adapt to the rapidly changing global healthcare ecosystem\, and to the rapidly changing needs and dynamics of its customers. In essence: Understand Digital Marketing and the Evolution of The Engagement Model In The Era of AI. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2UrQr1e
URL:https://www.pharmajournalist.com/event/digital-pharma-europe/
LOCATION:Merck Serono Headquarters\, Via Casilina 125\, Rome\, 00176\, Italy
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190605
DTSTAMP:20260515T010352
CREATED:20190228T102509Z
LAST-MODIFIED:20190228T102724Z
UID:19778-1559520000-1559692799@www.pharmajournalist.com
SUMMARY:Lyophilisation
DESCRIPTION:SMi Presents their 7th Annual Lyophilisation Conference \nSMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019\, in London\, UK. \n \nLyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020\, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion. \nAttend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science\, materials characterisation\, novel and alternative technologies\, mathematical modelling and regulatory updates. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \nCHAIRS FOR 2019  \nSune Klint Andersen\, Principal Spray Drying\, Janssen Pharmaceuticals \nXiaodong Chen\, Senior Research Investigator\, Bristol-Myers Squibb \nKEY SPEAKERS INCLUDE: \n\nPaul Matejtschuk\, Principal Scientist & Section Head\, Standardisation Science\, NIBSC\nDavide Fissore\, Associate Professor\, Politecnico di Torino\nMichael Dekner\, Head Fill & Finish LCM support\, Takeda\nRichard Denk\, Head Sales Containment\, Skan AG\nMostafa Nakach\, Head of Pharmaceutical Engineering Group\, Sanofi-Aventis R&D\nDaryl Williams\, Professor of Particle Science and Director of Discovery space\, Imperial College London\nKevin Ward\, Director of R&D\, Biopharma technology\nPaul Barry\, Development Scientist\, Genzyme Ireland Ltd/Sanofi\n\n2019 HIGHLIGHTS \n\nExplore the recent advances in lyophilisation methods and technologies from Biopharma Technology\nDiscuss the novel methods that characterise complex pharmaceutical products to aid formulation design from NIBSC\nGain insight into the approaches to avoid cross contamination during lyophilisation from SKAN AG\nDiscover a new approach towards process design through the use of micro freeze dryers by Politecno di Torino\nExamine the use of model-based approach to lyophilisation cycle design from Takeda\n\nFor more information on 7th Annual Lyophilisation Conference\, visit: www.lyophilisation-europe.com/PJ \nEarly-Bird Rates \n\nBOOK BY 29TH MARCH AND SAVE £400\nBOOK BY 30TH APRIL AND SAVE £200\nBOOK BY 31ST MAY AND SAVE £100\n\nContact Info\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilisation-conference-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190529
DTEND;VALUE=DATE:20190531
DTSTAMP:20260515T010352
CREATED:20180206T133206Z
LAST-MODIFIED:20190516T105109Z
UID:9281-1559088000-1559260799@www.pharmajournalist.com
SUMMARY:Skin Microbiome Congress
DESCRIPTION:Skin Microbiome Congress\nRevere Hotel Boston Common 200 Stuart St\, Boston\, MA 02116\, USA\n29 – 30 May\, 2019 \n“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” – Mike Conti\, Solabia \n \n2018 saw the microbiome move to the forefront of over 300 industry leaders\, who came together to exchange ideas at our Global Skin Microbiome Congress Series\, the first dedicated congress focusing solely on Skin Microbiome. \nWith the microbiome set to be the biggest trend in skincare for 2019\, we are incredibly excited to bring our flagship congress back to Boston\, building on our success globally and connecting over 300 industry leaders. \nThis year\, we take a deep-dive into the two key areas critical for success in this in this evolving field\, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome\, whereas track 2 will be focusing on building a commercial viable business. \nDon’t miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development\, as well as commercialization. \nThe inaugural Skin Microbiome Congress in 2018 SOLD OUT\, don’t miss your chance to attend this year’s event! \nTo learn more about Skin Microbiome Congress\, and to register online\, visit www.skinmicrobiomecongress.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190528
DTEND;VALUE=DATE:20190530
DTSTAMP:20260515T010352
CREATED:20190417T100847Z
LAST-MODIFIED:20190417T100847Z
UID:20361-1559001600-1559174399@www.pharmajournalist.com
SUMMARY:Healthcare Market Access & Pricing World Summit
DESCRIPTION:The 2nd annual Healthcare Market Access & Pricing Summit is the meeting place for the Healthcare Pricing\, Market Access\, Reimbursement\, HEOR\, and RWE community. \nSenior level experts from companies such as Abbott\, Merck\, Allergan\, and Johnson & Johnson among others will give you valuable insights through various interactive sessions. \nWith hot session topics like biosimilars\, orphan drugs and rare diseases\, this conference will provide a total and complete insight into the latest developments in the healthcare space\, may it be Pharma\, MedTech\, Biopharma or Biotech. \nJoin over 60+ healthcare professionals in May\, and book your ticket now!
URL:https://www.pharmajournalist.com/event/healthcare-market-access-pricing-world-summit/
LOCATION:NH Frankfurt Airport West Kelsterbacher Str. 19\, 65479 Germany
ORGANIZER;CN="Engaged Communications":MAILTO:sales@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T010352
CREATED:20190213T123725Z
LAST-MODIFIED:20190213T124118Z
UID:19536-1558569600-1558655999@www.pharmajournalist.com
SUMMARY:Microbiome Invest
DESCRIPTION:Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors\, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
URL:https://www.pharmajournalist.com/event/microbiome-invest-2/
LOCATION:London (Venue TBC)
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190525
DTSTAMP:20260515T010352
CREATED:20190118T101935Z
LAST-MODIFIED:20190118T101935Z
UID:19147-1558569600-1558742399@www.pharmajournalist.com
SUMMARY:RE•WORK Deep Learning in Healthcare Summit\, Boston
DESCRIPTION:The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders\, academics\, researchers\, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging\, diagnostics\, personalized medicine and how these are applied within pharmaceuticals\, patient care\, and health and wellbeing. The summit is a great way to discover the latest insights\, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community. \nDiscount Code: MP20 
URL:https://www.pharmajournalist.com/event/re%e2%80%a2work-deep-learning-in-healthcare-summit-boston/
LOCATION:InterContinental® Boston\, 510 Atlantic Avenue\, Massachusetts 02210
ORGANIZER;CN="RE%E2%80%A2WORK":MAILTO:luke@re-work.co
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T010352
CREATED:20190404T072211Z
LAST-MODIFIED:20190404T072453Z
UID:20182-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:5th Precision CRISPR Genome Editing Congress
DESCRIPTION:Designed with CRISPR experts from AstraZeneca\, AbbVie\, Broad Institute\, Casebia\, Merck\, Amgen and academics worldwide\, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery\, safety\, precision\, and efficiency to further optimize the relevant areas of drug discovery\, functional screening & CRISPR-based cell & gene therapy. \n \n\nLearn about how CRISPR is working in a clinical setting and unique approaches to gene therapy\nDiscover advances in disease modeling and strategies improving validation of human biology\nUnderstand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox\nExplore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases\nDiscover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline\nParticipate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR\n\nWith 100+ thought-leaders converging\, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network. \nTo learn more about this event\, visit https://ter.li/tjkmgn
URL:https://www.pharmajournalist.com/event/5th-precision-crispr-genome-editing-congress/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T010352
CREATED:20190206T125335Z
LAST-MODIFIED:20190206T125335Z
UID:19387-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:NDD Europe 2019
DESCRIPTION:Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics \n \nMultiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success. \nNDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration\, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers. \nWith 70+ thought-leaders converging at NDD Europe\, this will be an unrivalled opportunity for you to gain the latest scientific insights\, have your peers review your research and grow your collaborator network.
URL:https://www.pharmajournalist.com/event/ndd-europe-2019/
LOCATION:Hilton Paris La Defense\, 2 Place de la Défense\, 92800\, Puteaux\, France\, France
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T010352
CREATED:20181214T110222Z
LAST-MODIFIED:20181214T110356Z
UID:18840-1558396800-1558569599@www.pharmajournalist.com
SUMMARY:3rd Annual Digi-Tech Pharma 2019
DESCRIPTION:Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019)\, will provide a platform to all its participants an opportunity to interact\, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced\, new strategies\, case studies and use of innovative ideas in the field of Digital Pharma IT. Also\, to stay updated on the latest trends in digital\, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/3rd-annual-digi-tech-pharma-2019/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T010352
CREATED:20190213T092120Z
LAST-MODIFIED:20190214T153920Z
UID:19511-1558310400-1558655999@www.pharmajournalist.com
SUMMARY:TIDES: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization. \n \n1000+ Oligonucleotide & Peptide Scientists and Executives\nFast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma\, biotechs\, academia and solution providers from North America\, Asia and Europe. \n90+ Exhibitors\nConnect with leading manufacturing\, technologies\, and service providers to drive your promising therapeutic towards commercial success. \n125+ Case Studies and New Data Presentations\nHear best practices\, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production. \nRegister now at www.TIDESEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/tides-oligonucleotide-peptide-therapeutics/
LOCATION:Manchester Grand Hyatt | San Diego\, CA
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T010352
CREATED:20190108T102702Z
LAST-MODIFIED:20190108T102702Z
UID:18969-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Plant Genomics and Gene Editing Congress: Europe
DESCRIPTION:Global Engage is pleased to announce the 7th Plant Genomics & Gene Editing Congress: Europe\, taking place 21st-22nd May 2019\, in Rotterdam\, The Netherlands. This event is part of our widely-regarded Plant Genomics Series which includes an Asian and US meeting each year. \nAttracting over 300 experts working in all areas of plant science\, this event will examine the latest in gene editing methods for plant genomics research. CRISPR/Cas9 case studies and the very best strategies for plant genome engineering will be presented by industry leaders\, experts\, and pioneering academics at the forefront of plant research. Developments in gene editing\, NGS\, and omic technologies will all be explored for crop trait development\, disease resistance\, epigenetics\, plant breeding\, and more. Tracks dedicated to plant & soil microbiomes\, and the importance of plant phenotyping in the context of bioinformatics challenges\, will encourage a holistic approach to plant research; the former will focus on identifying microbes to enhance crop productivity & disease resistance\, while the latter will showcase the best tools for overcoming bioinformatics bottlenecks\, applicable to plant research across the board. We will also be looking to examine the impact of the ECJ’s latest interpretation of GMO regulations\, and what this means for the future of gene editing research\, addressing issues such as how to navigate the new legislation\, and considering what alternative strategies & technologies there might be for progressing plant genomics.
URL:https://www.pharmajournalist.com/event/plant-genomics-and-gene-editing-congress-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T010352
CREATED:20190108T102413Z
LAST-MODIFIED:20190108T102413Z
UID:18964-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Microbiome & Probiotics Series: Europe
DESCRIPTION:Part of the leading global microbiome and probiotics conference series\, the 2019 European event will bring together more than 400 industry\, academic\, and investment leaders to discuss the must cutting-edge microbiome and probiotics research\, challenges and opportunities in moving research towards commercialisation\, and potential partnerships and collaborations. \nFor the first time\, this event will be three days. As an attendee\, you will get more in-depth content on the key challenges and topics facing researchers and product developers\, and more time to establish partnerships. Hear from top scientists in the field\, meet willing investors and collaborators\, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions\, there will be many opportunities to broaden your connections.
URL:https://www.pharmajournalist.com/event/microbiome-probiotics-series-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190522
DTSTAMP:20260515T010352
CREATED:20190108T101939Z
LAST-MODIFIED:20190108T103213Z
UID:18959-1558310400-1558483199@www.pharmajournalist.com
SUMMARY:Global Bioprocessing\, Bioanalytics and ATMP Manufacturing Congress
DESCRIPTION:This comprehensive two-day congress features 30 presentations given across four tracks. It will provide experts with an exceptional environment in which to examine the key developments occurring today. Topics covered includethe automation of vaccine formulations\, purification technologies\, T-cell manufacturing and glycoanalytic technologies.
URL:https://www.pharmajournalist.com/event/global-bioprocessing-bioanalytics-and-atmp-manufacturing-congress/
LOCATION:Dublin\, Ireland\, Hotel Riu Plaza The Gresham Dublin\, Dublin\, Ireland
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190515
DTEND;VALUE=DATE:20190517
DTSTAMP:20260515T010352
CREATED:20190114T083448Z
LAST-MODIFIED:20190123T091623Z
UID:19074-1557878400-1558051199@www.pharmajournalist.com
SUMMARY:SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
DESCRIPTION:The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019. \nThe global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%. \n \nInjectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently\, there has been a focus on novel drug delivery\, including needle-free injectors\, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually\, injectables were used for delivery of hormones\, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins\, including high viscosity and high volume. Self-administrative\, connected\, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices. \nThe benefits of attending: \nDeveloping on last year’s success\, this event assembles an international audience to include regulatory\, device design\, packaging and formulation professionals.  The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends\, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape. \nThis conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following: \n– Life cycle management for developing devices that are both user friendly and revenue effective\n– Device design considerations\n– Long acting injectables and bringing these therapeutics to market with case studies\n– Connected devices\, GDPR and cyber security programs\n– Developments in primary packaging\n– Growth in transdermal delivery and subcutaneous infusion devices\n– Digital health partnerships\n– Large volume patch pump innovation examples \nWho should attend \nExecutives\, Directors\, VPs\, Heads\, Principals\, Managers\, Scientists\, Researchers of: \n\nAutoinjectors\nWearables\nDevice Engineering\nHuman Factors\nCMC\nInjectables\nSterile Manufacturing\nPackaging\nRegulatory Affairs\n\nFeatured Speakers: \n\nBjorg K. Hunter\, Device Engineering Manager\, GSK\nMiranda Newbery\, Human Factors Consultant\, Inspired Usability\nBlake Green\, Regulatory Affairs Senior Manager\, Devices\, Amgen\nQuentin Le Masne\, Head of Engineering team – Electro-Medical / Drug Delivery Devices\, Merck\nVasco Filipe\, Formulation and Drug Process Development Section Head for Biologics\, Sanofi\nStephen Paboojian\, Senior Project Leader I for Device Development\, Novartis\nTom Lawrie-Fussey\, Digital Services Specialist\, Cambridge Design Partnership\nTerry Reed\, Director of Business development\, AstraZeneca\nJoel Richard\, Head of Technical and Pharmaceutical Operations\, MedinCell\n\n*Plus\, pre-conference workshops – 14th May 2019 \nEARLY-BIRD RATES: \n\nBOOK BY 31st JANUARY AND SAVE £400\nBOOK BY 28th FEBRUARY AND SAVE £200\nBOOK BY 29th MARCH AND SAVE £100\n\nLinkedIn: @SMi Pharma \nTwitter: @SMiPharm #SMi \nTo learn more about this event\, and to register online\, visit www.injectable-drug-delivery.com/pharmajwl
URL:https://www.pharmajournalist.com/event/injectable-drug-delivery-2019/
LOCATION:Copthorne Tara Hotel London Kensington\, Copthorne Tara Hotel London Kensington\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190508
DTEND;VALUE=DATE:20190510
DTSTAMP:20260515T010352
CREATED:20181214T105212Z
LAST-MODIFIED:20181214T105212Z
UID:18835-1557273600-1557446399@www.pharmajournalist.com
SUMMARY:GLOBAL CLINICAL TRIALS CONNECT 2018 (Collaboration\, Innovation And Enhancing Quality In Clinical Trials )
DESCRIPTION:The  Global Clinical Trials Connect 2019 conference focuses on introducing pioneer technology\, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail\, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency. This conference will bring together the industry experts and leaders across pharmaceutical\, biotechnological and CRO’s for brainstorming on Case studies on innovation\, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises\, methodologies in trial design and many more.
URL:https://www.pharmajournalist.com/event/global-clinical-trials-connect-2018-collaboration-innovation-and-enhancing-quality-in-clinical-trials/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190507
DTEND;VALUE=DATE:20190510
DTSTAMP:20260515T010352
CREATED:20190313T080024Z
LAST-MODIFIED:20190313T080024Z
UID:19944-1557187200-1557446399@www.pharmajournalist.com
SUMMARY:Extractables & Leachables USA 2019
DESCRIPTION:Extractables & Leachables USA brings together leading E&L experts and decision makers from across the supply chain to get the latest updates on regulations\, best practices\, safety compliance\, biocompatibility\, advancements in the sector\, working group updates\, and much more. Taking place May 7-9\, 2019\, at the Westin Arlington Gateway in Arlington\, Virginia – this event offers the unique opportunity to make new connections\, network with peers\, share new information\, and discuss the key topics\, trends\, and new industry developments that are affecting the E&L marketplace. Use code PHARM19 to SAVE 15% off the current ticket price!
URL:https://www.pharmajournalist.com/event/extractables-leachables-usa-2019/
LOCATION:Westin Arlington Gateway – 801 N Glebe Rd\, Arlington\, VA 22203\, United States
ORGANIZER;CN="Smithers Rapra":MAILTO:aszymanski@smithers.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190509
DTSTAMP:20260515T010352
CREATED:20190201T151752Z
LAST-MODIFIED:20190201T151752Z
UID:19366-1557100800-1557359999@www.pharmajournalist.com
SUMMARY:2nd Annual CKD3 Summit
DESCRIPTION:Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need. \n \nBringing together leading experts from innovative biotechs\, large pharma\, academia and key service provider companies\, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research. \nTo learn more and to register online\, visit https://ter.li/10so2k
URL:https://www.pharmajournalist.com/event/2nd-annual-ckd3-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190430
DTEND;VALUE=DATE:20190502
DTSTAMP:20260515T010352
CREATED:20190110T103553Z
LAST-MODIFIED:20190110T110108Z
UID:18984-1556582400-1556755199@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to the West Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 6th Annual Clinical Operations in Oncology Trials to the West Coast on April 30th – May 1st 2019. \nAs one of the only oncology operationally focused events in the West Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage West Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the West Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nWe hope to see you in April\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-the-west-coast-2019/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190423
DTEND;VALUE=DATE:20190426
DTSTAMP:20260515T010352
CREATED:20190220T073616Z
LAST-MODIFIED:20190220T073737Z
UID:19651-1555977600-1556236799@www.pharmajournalist.com
SUMMARY:European NeoAg Summit
DESCRIPTION:With an exclusive case-study led agenda\, the European NeoAg Summit will paint a fuller picture of neoantigen presentation and T-cell interaction. Hear updates on clinical trials results to help you further determine neoantigen immunogenicity. \nIn addition\, gain practical insights on personalised cancer vaccine and cell therapy global clinical development\, as well as regulatory guidance. \nJoin the gathering of over 100 personalised cancer immunotherapy pioneers from pharma and biotech including Ziopharm\, Genocea\, Vaccibody and more to advance neoantigen based cancer vaccines and cell therapies. \nFor more information\, visit www.neoantigen-europe.com 
URL:https://www.pharmajournalist.com/event/european-neoag-summit/
LOCATION:Amsterdam Marriot Hotel  Stadhouderskade 12\, 1054 ES  Amsterdam\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190419
DTSTAMP:20260515T010352
CREATED:20190220T073216Z
LAST-MODIFIED:20190220T073349Z
UID:19646-1555372800-1555631999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit (NIDD)
DESCRIPTION:Built with thought-leaders at Sanofi\, Eisai\, AbbVie and Denali\, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases. \n\nWith an emphasis on neurodegeneration\, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges: \n\nDiscover robust biomarkers of neuroinflammation to enable successful translation and patient stratification\nNavigate preclinical model limitations to better predict clinical efficacy\nExplore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches\n\nDon’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic. \nFor more information\, visit www.neuroimmunology-drugdevelopment.com
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-nidd/
LOCATION:Hyatt Regency Boston  One Avenue de Lafayette\, Boston  Massachusetts\, United States\, 02111
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260515T010352
CREATED:20190108T073610Z
LAST-MODIFIED:20190108T073610Z
UID:18942-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:CAR-T Congress USA
DESCRIPTION:CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite\, the race is on to lead the commercialization of safe\, efficacious and accessible CAR-T therapy. \n \nThe fourth annual CAR-T congress USA provides a platform for emerging novel data in small scale clinical trials ran by the leading academic institutions\, including MD Anderson and the University of Pennsylvania. \nHear first-hand\, the emerging areas of research from new companies into single patient experiences\, as well as context around patient relapses and methods of toxicity management. \nJoin thought leaders from biotechs\, pharmaceutical companies and academia to address the challenges of CAR-T therapy including toxicity\, scalability and efficacy in both liquid and solid tumours. \nDiscover how CAR-T compares to standard treatments and advances in genome editing tools\, the new methods in allogeneic and autologous process development and the pre-clinical concepts that will pave the way for novel antigen discovery. \nBe part of the movement that engineers a strategy to reprogram the cancer treatments we know today. \nBook before January 25 to save up to $800.  To learn more about this event and to book online visit: www.car-tcongress.com/register
URL:https://www.pharmajournalist.com/event/car-t-congress-usa/
LOCATION:Hyatt Regency Boston Harbor\, 101 Harborside Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260515T010352
CREATED:20181005T132158Z
LAST-MODIFIED:20181005T132334Z
UID:17940-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:17th annual eyeforpharma Philadelphia Conference
DESCRIPTION:Where pharma’s performance is built by patient value \nThe world’s greatest gathering of pharma’s value-designers \nEvery important industry player in one room\, evolving our antiquated model by embracing value-based care. That’s the vision for eyeforpharma Philadelphia\, the flagship event where pharma\, patients and payers co-design for outcomes. \nThere are dozens of events on digital\, on patient centricity\, on data\, on access\, on medical\, on commercial. Only one event brings all the key designers together so that we can address unmet need\, create solutions that cover the spectrum\, and end the age-old problems of misalignment. \nJoin us for pharma’s most influential meeting – as we write the blueprint for healthcare’s future. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2O8ldd5
URL:https://www.pharmajournalist.com/event/17th-annual-eyeforpharma-philadelphia-conference/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="eyeforpharma":MAILTO:jbramwell@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190401
DTEND;VALUE=DATE:20190403
DTSTAMP:20260515T010352
CREATED:20181121T114612Z
LAST-MODIFIED:20181130T122336Z
UID:18473-1554076800-1554249599@www.pharmajournalist.com
SUMMARY:Adaptive Designs in Clinical Trials 2019
DESCRIPTION:SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology. \n \nHosting in depth presentations from regulatory agencies\, researchers and biostatisticians\, the meeting will cover how personalized medicine\, platform trials\, response-adaptive randomization\, signature designs\, estimand framework\, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America. \nTo learn more and to register online\, visit www.adaptivedesigns.co.uk/pharmajwl
URL:https://www.pharmajournalist.com/event/adaptive-designs-in-clinical-trials-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190327
DTEND;VALUE=DATE:20190328
DTSTAMP:20260515T010352
CREATED:20190308T084926Z
LAST-MODIFIED:20190308T084926Z
UID:19867-1553644800-1553731199@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:The Pharma Gorilla will be held on March 27\, 2019 in Hilton Mumbai International Airport\, Mumbai\, India. It provides the opportunity to learn\, engage and network for the pharmaceutical and healthcare fraternity. This conference is designed to address practical issues and topics for Corporates\, scientists\, professors\, business representatives\, and healthcare providers to discuss the latest innovations\, trends and concerns\, practical challenges and solutions in Pharma. \nThe objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla/
LOCATION:Hilton Mumbai International Airport\, Mumbai\, India
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190326
DTEND;VALUE=DATE:20190328
DTSTAMP:20260515T010352
CREATED:20190110T101919Z
LAST-MODIFIED:20190110T101919Z
UID:18980-1553558400-1553731199@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England 2019
DESCRIPTION:This year’s Clinical Trial Supply New England celebrates its 8th year and will be hosted on the 26th – 27th of March. \nIn 2019 we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s success conference and are returning with full force to Boston with the aim of supporting trial sponsors and solution providers across New England to ensure trials are delivered on time\, partnerships are improved and supply chain uncertainties are resolved. \nWe will once again be meeting in to discuss\, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s dedicated Clinical Trial Supply conference for the New England area\, this event caters to local needs while offering the change to meet international sponsors and solution providers. \nAt each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies\, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies\, thought leading presentations and engaging panels. \nThis year we will be looking at those issues which are affecting companies in the Boston-Cambridge hub\, such as but no limited to: ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain\, discovering how to incorporate gene therapies within your supply chain and blockchain: a discussion of practical applications for clinical supply chain and life-sciences. \nWith such a packed program you can’t afford to miss out. We look forward to meeting you in Boston so make sure to book your place today!
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england-2019/
LOCATION:Boston\, Massachusetts
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
END:VCALENDAR